Published in Trends Parasitol on April 24, 2006
The future of onchocerciasis control in Africa. PLoS Negl Trop Dis (2007) 1.35
Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors. Afr Health Sci (2013) 1.20
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg (2010) 0.94
Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol (2014) 0.94
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity. PLoS Negl Trop Dis (2012) 0.93
African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases. PLoS Negl Trop Dis (2015) 0.78
A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia. Am J Trop Med Hyg (2010) 0.75
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis. Sci Rep (2016) 0.75
Ivermectin 20 years on: maturation of a wonder drug. Trends Parasitol (2005) 2.90
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Effects of standard and high doses of ivermectin on adult worms of Onchocerca volvulus: a randomised controlled trial. Lancet (2002) 7.25
River blindness: a success story under threat? PLoS Med (2006) 2.55
Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis (2008) 1.88
Dengue spatial and temporal patterns, French Guiana, 2001. Emerg Infect Dis (2004) 1.86
Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J (2003) 1.70
Th2 cytokines are associated with reduced worm burdens in a human intestinal helminth infection. J Infect Dis (2003) 1.64
Epilepsy in onchocerciasis endemic areas: systematic review and meta-analysis of population-based surveys. PLoS Negl Trop Dis (2009) 1.58
Genetic selection of low fertile Onchocerca volvulus by ivermectin treatment. PLoS Negl Trop Dis (2007) 1.44
Human infection patterns and heterogeneous exposure in river blindness. Proc Natl Acad Sci U S A (2005) 1.38
Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis (2011) 1.26
Intensity of intestinal infection with multiple worm species is related to regulatory cytokine output and immune hyporesponsiveness. J Infect Dis (2008) 1.24
Identifying sub-optimal responses to ivermectin in the treatment of River Blindness. Proc Natl Acad Sci U S A (2009) 1.21
T helper cell type 2 responsiveness predicts future susceptibility to gastrointestinal nematodes in humans. J Infect Dis (2004) 1.21
Mapping the distribution of Loa loa in Cameroon in support of the African Programme for Onchocerciasis Control. Filaria J (2004) 1.16
Allergen-specific IgE and IgG4 are markers of resistance and susceptibility in a human intestinal nematode infection. Microbes Infect (2005) 1.13
Age- and infection intensity-dependent cytokine and antibody production in human trichuriasis: the importance of IgE. J Infect Dis (2002) 1.09
Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp. Am J Trop Med Hyg (2008) 1.08
Hair mercury levels in Amazonian populations: spatial distribution and trends. Int J Health Geogr (2009) 1.05
Case-control studies on the relationship between onchocerciasis and epilepsy: systematic review and meta-analysis. PLoS Negl Trop Dis (2013) 1.05
Loa loa microfilarial periodicity in ivermectin-treated patients: comparison between those developing and those free of serious adverse events. Am J Trop Med Hyg (2009) 1.03
Onchocerciasis: the pre-control association between prevalence of palpable nodules and skin microfilariae. PLoS Negl Trop Dis (2013) 1.02
P-glycoprotein-like protein, a possible genetic marker for ivermectin resistance selection in Onchocerca volvulus. Mol Biochem Parasitol (2007) 1.00
Demographic impact of epilepsy in Africa: results of a 10-year cohort study in a rural area of Cameroon. Epilepsia (2003) 0.98
LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection. Infect Immun (2002) 0.96
Mapping disease incidence in suburban areas using remotely sensed data. Am J Epidemiol (2002) 0.96
Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon. PLoS Negl Trop Dis (2013) 0.96
Evaluation of the diethylcarbamazine patch to evaluate onchocerciasis endemicity in Central Africa. Trop Med Int Health (2007) 0.96
Fifteen years of annual mass treatment of onchocerciasis with ivermectin have not interrupted transmission in the west region of cameroon. J Parasitol Res (2013) 0.95
Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg (2010) 0.94
Head nodding syndrome and river blindness: a parasitologic perspective. Epilepsia (2009) 0.92
Semi-quantitative scoring of an immunochromatographic test for circulating filarial antigen. Am J Trop Med Hyg (2013) 0.92
After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Trop Med Int Health (2008) 0.91
Th2 responses predominate during the early phases of infection in patients with localized cutaneous leishmaniasis and precede the development of Th1 responses. Infect Immun (2003) 0.91
Where next with Loa loa encephalopathy? Data are badly needed. Trends Parasitol (2007) 0.90
Adverse systemic reactions to treatment of onchocerciasis with ivermectin at normal and high doses given annually or three-monthly. Trans R Soc Trop Med Hyg (2004) 0.90
Indoor metallic pollution related to mining activity in the Bolivian Altiplano. Environ Pollut (2011) 0.88
Lymphatic vascularisation and involvement of Lyve-1+ macrophages in the human onchocerca nodule. PLoS One (2009) 0.87
Onchocerciasis, cysticercosis, and epilepsy. Am J Trop Med Hyg (2008) 0.87
Mayaro virus in wild mammals, French Guiana. Emerg Infect Dis (2003) 0.87
Single nucleotide polymorphisms in β-tubulin selected in Onchocerca volvulus following repeated ivermectin treatment: possible indication of resistance selection. Mol Biochem Parasitol (2012) 0.86
Associations between filarial and gastrointestinal nematodes. Trans R Soc Trop Med Hyg (2005) 0.86
A randomized, double-blind, controlled trial of the effects of ivermectin at normal and high doses, given annually or three-monthly, against Onchocerca volvulus: ophthalmological results. Trans R Soc Trop Med Hyg (2005) 0.86
A possible case of spontaneous Loa loa encephalopathy associated with a glomerulopathy. Filaria J (2006) 0.86
A case study of risk factors for lymphatic filariasis in the Republic of Congo. Parasit Vectors (2014) 0.84
Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). Trans R Soc Trop Med Hyg (2007) 0.83
Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med (2012) 0.83
Influence of source distribution and geochemical composition of aerosols on children exposure in the large polymetallic mining region of the Bolivian Altiplano. Sci Total Environ (2011) 0.82
Hair trace elements concentration to describe polymetallic mining waste exposure in Bolivian Altiplano. Biol Trace Elem Res (2010) 0.81
Significant association between epilepsy and presence of onchocercal nodules: case-control study in Cameroon. Am J Trop Med Hyg (2012) 0.81
Onchocerciasis-related epilepsy? Prospects at a time of uncertainty. Trends Parasitol (2005) 0.81
Child neurodevelopment in a Bolivian mining city. Environ Res (2011) 0.81
An acute foodborne outbreak due to Plesiomonas shigelloides in Yaounde, Cameroon. Foodborne Pathog Dis (2006) 0.81
Genetic heterogeneity in Loa loa parasites from southern Cameroon: A preliminary study. Filaria J (2004) 0.80
Individual host factors associated with Onchocerca volvulus microfilarial densities 15, 80 and 180 days after a first dose of ivermectin. Acta Trop (2010) 0.80
Case report: Loiasis with peripheral nerve involvement and spleen lesions. Am J Trop Med Hyg (2011) 0.79
Absence of an association between Plasmodium falciparum infection and post-ivermectin Loa-related non-neurologic serious adverse events. Am J Trop Med Hyg (2014) 0.78
A comparison of cellular and humoral immune responses to trichuroid derived antigens in human trichuriasis. Parasite Immunol (2002) 0.78
Child patterns of growth delay and cognitive development in a Bolivian mining city. Am J Hum Biol (2012) 0.78
Mercury exposure in a high fish eating Bolivian Amazonian population with intense small-scale gold-mining activities. Int J Environ Health Res (2009) 0.78
Erythropoietin for treating post-ivermectin Loa-related serious adverse events? Trends Parasitol (2009) 0.77
African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan). Trans R Soc Trop Med Hyg (2007) 0.77
Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon. Parasit Vectors (2013) 0.76
A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia. Am J Trop Med Hyg (2010) 0.75